Transcatheter Aortic Valve Replacement/Implantation Market Expected To Rise By 2026, Estimates DelveInsight
In November 2020, Boston Scientific Corp. announced the immediate retirement of the entire Lotus Edge transcatheter aortic valve replacement (TAVR) system. In October 2020, Medtronic announced that it will begin a randomized, head-to-head study comparing two transcatheter aortic valve replacement (TAVR) systems in patients with severe symptomatic aortic stenosis (ssAS). In August 2019, Medtronic plc received U.S. Food and Drug Administration (FDA) approval for the indication expansion of the Evolut™ Transcatheter Aortic Valve Replacement (TAVR) system for patients with symptomatic severe...